Cargando…

Obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy

Obesity is associated with the development of left ventricular (LV) hypertrophy. Whether obesity in in the absence of comorbidities can cause LV hypertrophy to an extent which could create diagnostic uncertainty with pathological states (such as hypertrophic cardiomyopathy) is unknown. We used cine...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Andrew J. M., Rayner, Jennifer J., Abdesselam, Ines, Neubauer, Stefan, Rider, Oliver J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286928/
https://www.ncbi.nlm.nih.gov/pubmed/33730330
http://dx.doi.org/10.1007/s10554-021-02207-1
_version_ 1783723813530238976
author Lewis, Andrew J. M.
Rayner, Jennifer J.
Abdesselam, Ines
Neubauer, Stefan
Rider, Oliver J.
author_facet Lewis, Andrew J. M.
Rayner, Jennifer J.
Abdesselam, Ines
Neubauer, Stefan
Rider, Oliver J.
author_sort Lewis, Andrew J. M.
collection PubMed
description Obesity is associated with the development of left ventricular (LV) hypertrophy. Whether obesity in in the absence of comorbidities can cause LV hypertrophy to an extent which could create diagnostic uncertainty with pathological states (such as hypertrophic cardiomyopathy) is unknown. We used cine cardiovascular magnetic resonance imaging to precisely measure LV wall thickness in the septum and lateral wall in 764 people with body mass indices ranging from 18.5 kg/m(2) to 59.2 kg/m(2) in the absence of major comorbidities. Obesity was related to LV wall thickness across the cohort (basal septum r 0.30, P < 0.001 and basal lateral wall r 0.18, P < 0.001). Although no participant had hypertension, these associations remained highly significant after controlling for systolic blood pressure (all P < 0.01). Each 10 kg/m(2) increase in BMI was associated with an increase in basal septal wall thickness of 1.0 mm males and 0.8 mm in females, with no statistically significant difference between genders (P = 0.1). Even in class 3 obesity (BMI > 40 kg/m(2)), no LV wall thickness > 13.4 mm in males or > 12.7 mm in females was observed in this cohort. We confirm that obesity in the absence of comorbidities is associated with LV hypertrophy, and establish that the magnitude of this change is modest even in severe obesity. LV hypertrophy > 14 mm cannot safely be attributed to obesity alone and alternative diagnoses should be considered.
format Online
Article
Text
id pubmed-8286928
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-82869282021-07-20 Obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy Lewis, Andrew J. M. Rayner, Jennifer J. Abdesselam, Ines Neubauer, Stefan Rider, Oliver J. Int J Cardiovasc Imaging Original Article Obesity is associated with the development of left ventricular (LV) hypertrophy. Whether obesity in in the absence of comorbidities can cause LV hypertrophy to an extent which could create diagnostic uncertainty with pathological states (such as hypertrophic cardiomyopathy) is unknown. We used cine cardiovascular magnetic resonance imaging to precisely measure LV wall thickness in the septum and lateral wall in 764 people with body mass indices ranging from 18.5 kg/m(2) to 59.2 kg/m(2) in the absence of major comorbidities. Obesity was related to LV wall thickness across the cohort (basal septum r 0.30, P < 0.001 and basal lateral wall r 0.18, P < 0.001). Although no participant had hypertension, these associations remained highly significant after controlling for systolic blood pressure (all P < 0.01). Each 10 kg/m(2) increase in BMI was associated with an increase in basal septal wall thickness of 1.0 mm males and 0.8 mm in females, with no statistically significant difference between genders (P = 0.1). Even in class 3 obesity (BMI > 40 kg/m(2)), no LV wall thickness > 13.4 mm in males or > 12.7 mm in females was observed in this cohort. We confirm that obesity in the absence of comorbidities is associated with LV hypertrophy, and establish that the magnitude of this change is modest even in severe obesity. LV hypertrophy > 14 mm cannot safely be attributed to obesity alone and alternative diagnoses should be considered. Springer Netherlands 2021-03-17 2021 /pmc/articles/PMC8286928/ /pubmed/33730330 http://dx.doi.org/10.1007/s10554-021-02207-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Lewis, Andrew J. M.
Rayner, Jennifer J.
Abdesselam, Ines
Neubauer, Stefan
Rider, Oliver J.
Obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy
title Obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy
title_full Obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy
title_fullStr Obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy
title_full_unstemmed Obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy
title_short Obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy
title_sort obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286928/
https://www.ncbi.nlm.nih.gov/pubmed/33730330
http://dx.doi.org/10.1007/s10554-021-02207-1
work_keys_str_mv AT lewisandrewjm obesityintheabsenceofcomorbiditiesisnotrelatedtoclinicallymeaningfulleftventricularhypertrophy
AT raynerjenniferj obesityintheabsenceofcomorbiditiesisnotrelatedtoclinicallymeaningfulleftventricularhypertrophy
AT abdesselamines obesityintheabsenceofcomorbiditiesisnotrelatedtoclinicallymeaningfulleftventricularhypertrophy
AT neubauerstefan obesityintheabsenceofcomorbiditiesisnotrelatedtoclinicallymeaningfulleftventricularhypertrophy
AT rideroliverj obesityintheabsenceofcomorbiditiesisnotrelatedtoclinicallymeaningfulleftventricularhypertrophy